Cargando…

Vitamin D binding protein isoforms as candidate predictors of disease extension in childhood arthritis

INTRODUCTION. Juvenile idiopathic arthritis (JIA) comprises a poorly understood group of chronic autoimmune diseases with variable clinical outcomes. We investigated whether the synovial fluid (SF) proteome could distinguish a subset of patients in whom disease extends to affect a large number of jo...

Descripción completa

Detalles Bibliográficos
Autores principales: Gibson, David S., Newell, Keri, Evans, Alexandra N., Finnegan, Sorcha, Manning, Gwen, Scaife, Caitriona, McAllister, Catherine, Pennington, Stephen R., Duncan, Mark W., Moore, Terry L., Rooney, Madeleine E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3443749/
https://www.ncbi.nlm.nih.gov/pubmed/22771520
http://dx.doi.org/10.1016/j.jprot.2012.06.024
Descripción
Sumario:INTRODUCTION. Juvenile idiopathic arthritis (JIA) comprises a poorly understood group of chronic autoimmune diseases with variable clinical outcomes. We investigated whether the synovial fluid (SF) proteome could distinguish a subset of patients in whom disease extends to affect a large number of joints. METHODS. SF samples from 57 patients were obtained around time of initial diagnosis of JIA, labeled with Cy dyes and separated by two-dimensional electrophoresis. Multivariate analyses were used to isolate a panel of proteins which distinguish patient subgroups. Proteins were identified using MALDI-TOF mass spectrometry with expression verified by immunochemical methods. Protein glycosylation status was confirmed by hydrophilic interaction liquid chromatography. RESULTS. A truncated isoform of vitamin D binding protein (VDBP) is present at significantly reduced levels in the SF of oligoarticular patients at risk of disease extension, relative to other subgroups (p < 0.05). Furthermore, sialylated forms of immunopurified synovial VDBP were significantly reduced in extended oligoarticular patients (p < 0.005). CONCLUSION. Reduced conversion of VDBP to a macrophage activation factor may be used to stratify patients to determine risk of disease extension in JIA patients.